Study for People with Atopic Eczema

Study 583

We are looking for people with atopic dermatitis (atopic eczema) to participate in a drug trial.

The study examines an emulsion (a thin, fluid cream) currently under development for the treatment of atopic eczema. Atopic eczema is a chronic skin condition that causes itching, redness, and skin irritation.

The purpose of the study is to investigate the safety and tolerability of the investigational drug, as well as how it is absorbed, distributed, and excreted in the body. The new drug is based on a novel therapeutic principle and aims to restore balance to the immune system.

Target group: people with atopic eczema, ages 18–65

Criteria for participation:

• Have had atopic eczema for at least six months and currently have itchy eczema
• Do not smoke regularly (e.g., cigarettes, e-cigarettes, pipe)
• Must not have participated in another drug study in the last three months
• Have not donated blood in the past three months
• Be willing to use dual contraception during heterosexual intercourse, i.e., a condom and sterilization (men), AND use approved contraceptives, be sterilized, or be postmenopausal, and not be, or intend to become, pregnant or breastfeeding during the course of the study (women)

Group S1

The study consists of four visits to our clinic in Uppsala over a period of approximately 7 weeks: one health checkup, two treatment visits, and one follow-up visit. During the treatment visits, you will stay overnight at the clinic for two days and receive the study medication or placebo (without an active ingredient) in the form of an emulsion that is applied to the skin. During the first treatment visit, the cream will be applied to healthy skin, and during the second treatment visit, the emulsion will be applied to skin affected by atopic eczema.

Compensation: 12 ,320 SEK for your participation, plus the possibility of travel reimbursement.

Schedule:

Group S2

The study consists of three visits to our clinic in Uppsala over a period of about 6 weeks: a health checkup, a treatment visit, and a follow-up visit. During the treatment visit, you will stay overnight at the clinic for two days and receive the study medication or placebo (without an active ingredient) in the form of an emulsion applied to the skin affected by atopic eczema.

Compensation: 6,240 SEK for your participation, plus the possibility of travel reimbursement.

Schedule:

More information and registration

Would you like to participate in the study?Please submit an expression of interest using the form below.

Do you have any questions or want to know more?Call 018-30 33 99 or emailinfo@ctc-ab.se.

The study has been approved by the Swedish Ethical Review Authority and the Swedish Medical Products Agency. Your participation is voluntary, and you may withdraw at any time. The information you provide will be processed in accordance with the General Data Protection Regulation (GDPR).

Sign up here